about
Enucleation and development of cluster headache: a retrospective studyPhantom eye syndrome: Its prevalence, phenomenology, and putative mechanismsCombined intravitreal triamcinolone injection and laser photocoagulation in eyes with persistent macular edema after branch retinal vein occlusion.[Focal laser photocoagulation in patients with diabetic macular edema after pretreatment with triamcinolone: 6-month results].[Primary and secondary prophylaxis of AMD by antioxidants: current risk-benefit data].Ranibizumab in retinal vein occlusion: treatment recommendations by an expert panelIndividualized Stabilization Criteria-Driven Ranibizumab versus Laser in Branch Retinal Vein Occlusion: Six-Month Results of BRIGHTER.Combined Laser Photocoagulation and anti-VEGF Injection Treatment in Radiation Retinopathy.[Treatment guidelines in various stages of senile retinoschisis]A new approach towards a minimal invasive retina implant.Ocular findings in a family with autosomal dominant retinitis pigmentosa and a frameshift mutation altering the carboxyl terminal sequence of rhodopsin.Heavy internal tamponade for cases with complicated retinal detachment.Intravitreal anti-VEGF Treatment in Central Retinal Vein Occlusion (CRVO): a Meta-Analysis of One Year Results.Results of a Meta-Analysis on Intravitreal anti-VEGF Treatment of Macular Oedema Secondary to Branch Retinal Vein Occlusion (BRVO).Long-term Results of Intravitreal Anti-VEGF Injections in Wet AMD: A Meta-Analysis.Acid Violet 17: a New Dye for Chromovitrectomy?[Unusual Occlusion of the Central Retinal Vein in a 28-Year-Old Patient].Cluster headache after orbital exenteration.Chloroquine Retinopathy under Inadequately Weight Adjusted Dosage: Early Detection by Multimodal Imaging.Hemorrhagic complications after intravitreal injections of ranibizumab in patients under coumarin-type anticoagulation.Success rates of retinal buckling surgery: relationship to refractive error and lens status: results from a large German case series.Heavy internal tamponades and risk of hypotony.[Cataract development following posterior chamber phakic intraocular lens implantation in eyes with high myopia].[Electrical stimulation of the visual system. From empirical approach to visual prostheses]Ranibizumab treatment in age-related macular degeneration: a meta-analysis of one-year results.Retinal detachment and phthisis bulbi after implantation of an iris prosthetic system.Complications after prosthetic iris implantation in a case of traumatic aniridia.Illuminated artificial orbit for the training of vitreoretinal surgery in vitro.[Ocular hypotonia in leukemia].[Perfluorohexyloctane as internal tamponade in patients with complicated retinal detachment. Results after 6 months].Comparison of two partial coherence interferometry devices for ocular biometry.Three years follow-up results of ranibizumab treatment for choroidal neovascularization secondary to pathologic myopia.Sustained Benefits of Ranibizumab with or without Laser in Branch Retinal Vein Occlusion: 24-Month Results of the BRIGHTER Study.Intraocular use of acid violet 17 at a concentration of 1.5 mg/ml is not safe.Early visual evoked potentials: an indicator of bioelectrical activity of the lateral geniculate nucleus?Retinopathy after 30 Gray Whole Brain Radiation.[Fulminant Panendophthalmitis from Streptococcus pneumoniae after Removal of Corneal Suture].Closure of an Intraoperatively Enlarged Macular Hole by Revision Surgery with Free ILM Flaps.Intravital staining of the internal limiting membrane with a novel heavy solution of brilliant blue G.Experimental implantation of epiretinal retina implants (EPI-RET) with an IOL-type receiver unit.
P50
Q24794385-43E085B6-5F91-4FE0-B940-AF77A25BF070Q28203803-9E44ED54-D6EA-4ED1-B33F-44383735FED5Q33360807-E796DA50-A1B9-4E1C-BAC6-8ECE3E9033D3Q33560880-125F6FE6-3F60-4CB7-B38E-799A49558B93Q33560899-F7803144-2DF2-4F6F-A12A-06F79BB30199Q35135745-B4EAFEBF-A6A9-43B9-8CCF-A56717ED08E6Q35977986-7BE020E9-743D-485C-A450-A903A9740185Q36304592-50E4173A-8FDD-4201-A6EE-A2D80C2F18B4Q36702708-E718FFEB-AFED-4C84-9F6D-1096FBE0C927Q36746190-8CEF3BF5-24DC-4391-A6BE-BB40DAD16491Q37302751-379ADC4A-94C0-48EF-9D6A-2B59C410DCDDQ37864228-F3051D14-3C59-4EB8-ACCD-8BCCE2DDCCDAQ38926713-46706A07-BA3F-45E5-B81C-61BF51C1D4AEQ38963856-2A9F0BDD-4949-4EE8-BE44-8F7947014B96Q39020840-A070461D-885B-4A0B-AC95-2826F25079D6Q39820380-9D05D4F6-78AD-48B8-9081-37BA5FC533E1Q40698414-C5CA463D-6D10-4034-82BC-94128E9428B2Q41626519-6BF84D19-0D66-40B4-BE8F-CBB90AB17D74Q41913219-53E84EEF-7243-4EA2-9851-AEE71BE5E0BBQ43090947-BC143D95-6C22-4D21-A281-E3EE554FB6C0Q43140974-7B29C112-13AD-407D-9945-9F9581CD4200Q43234800-64C1C60B-B1A7-4959-9AF4-20FAEEB26C2EQ43738096-595A0F7E-5786-46EF-B67C-1CA0D1DF77A8Q43813124-6DC88B27-59CC-45E9-800E-4D1FFE5F2A17Q44193312-B0D2488C-E6E5-471B-8BE0-0CD06B325C83Q44461901-87241E82-EB17-4C79-86EC-0EC818131DD5Q44610520-643F917E-3E6A-4624-B7BC-8F742060DF6DQ44755489-240FC5E4-D7D1-44F6-A4C2-ECE03D33A76BQ44762030-870615B3-0765-43B0-BD92-DB9E8F1FFB63Q44791047-D1A9F27D-638A-41FA-AE96-C13786B338A7Q46369087-1DF75F95-1672-47B8-88FE-38F4A82FB2F5Q46468228-B0E81EC3-93B6-4FC4-94B4-5113EF9A8015Q47954147-359B1FC6-D551-412B-8B4A-65D0E66B7D23Q48355783-600C5095-B7F5-44A8-8E7D-0AC01445EDFCQ48572255-79A6BF8D-4B23-427E-80B8-F78B0162A06FQ48792594-2135DF7F-0F9D-4383-A774-AC0D29E457EDQ49922274-BEC14D20-3BC9-49C0-9BA4-54FB7CE6B6BAQ50062631-52E1C720-CD0F-4E43-A6DC-24CD77BA8081Q50278818-558C5B47-F829-4FFA-8C23-46EB8FD8D31FQ51060422-453E7888-17AE-46CA-95CC-AA3A4AE1B73D
P50
description
researcher
@en
name
Gerding H
@ast
Gerding H
@nl
Heinrich Gerding
@en
type
label
Gerding H
@ast
Gerding H
@nl
Heinrich Gerding
@en
altLabel
Gerding H
@en
prefLabel
Gerding H
@ast
Gerding H
@nl
Heinrich Gerding
@en
P106
P31
P496
0000-0003-3968-5601